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Downregulation of renal tubular Wnt/β-catenin
signaling by Dickkopf-3 induces tubular cell death in
proteinuric nephropathy
DW L Wong1,2, WH Yiu1,2, HJ Wu1,2, RX Li1,2, Y Liu1,2, KW Chan1,2, JC K Leung1, LY Y Chan1, KN Lai1 and SCW Tang*,1,2
Studies on the role of Wnt/β-catenin signaling in different forms of kidney disease have yielded discrepant results. Here, we report
the biphasic change of renal β-catenin expression in mice with overload proteinuria in which β-catenin was upregulated at the early
stage (4 weeks after disease induction) but abrogated at the late phase (8 weeks). Acute albuminuria was observed at 1 week after
bovine serum albumin injection, followed by partial remission at 4 weeks that coincided with overexpression of renal tubular
β-catenin. Interestingly, a rebound in albuminuria at 8 weeks was accompanied by downregulated tubular β-catenin expression and
heightened tubular apoptosis. In addition, there was an inverse relationship between Dickkopf-3 (Dkk-3) and renal tubular
β-catenin expression at these time points. In vitro, a similar trend in β-catenin expression was observed in human kidney-2 (HK-2)
cells with acute (upregulation) and prolonged (downregulation) exposure to albumin. Induction of a proapoptotic phenotype by
albumin was significantly enhanced by silencing β-catenin in HK-2 cells. Finally, Dkk-3 expression and secretion was increased
after prolonged exposure to albumin, leading to the suppression of intracellular β-catenin signaling pathway. The effect of Dkk-3
on β-catenin signaling was confirmed by incubation with exogenous Dkk-3 in HK-2 cells. Taken together, these data suggest that
downregulation of tubular β-catenin signaling induced by Dkk-3 has a detrimental role in chronic proteinuria, partially through the
increase in apoptosis.
Cell Death and Disease (2016) 7, e2155; doi:10.1038/cddis.2016.62; published online 24 March 2016
Chronic kidney disease (CKD) is a global public health
problem affecting approximately 10% of the world popu-
lation.1 Despite its diverse etiologies, progressive CKD is
characterized histologically by a common pathway of renal
tubulointerstitial damage.2 One established link between the
different forms of glomerular disease and lesions in the
interstitial compartment is proteinuria.
Notably, albumin is the most abundant protein in the
glomerular filtrate, which is reabsorbed by the proximal tubule
via receptor-mediated endocytosis.3,4 This process activates
a range of intracellular signaling pathways in renal cells5–7 and
triggers the tubular epithelial cells to enter a proinflammatory
state8 that heralds a profibrotic microenvironment with
accumulation of extracellular matrix.9 Abnormal protein traffi-
cking is also a causative factor of renal tubular cell death.10–12
An increasing number of experimental investigations and
clinical observations have proved renal tubular cell apoptosis
in the pathogenesis of renal tubular injury.13–15 Emerging
evidence indicates that some underlying tubulotoxic mechan-
isms of tubular cell death are stimulated by albumin overload.16
The canonical Wnt/β-catenin signaling pathway participates
in multiple physiological events associated with organ
repair and developmental processes.17,18 Emerging evidence
suggests that the Wnt/β-catenin signaling pathway may be
involved in different organ-specific diseases.19,20 In the
canonical Wnt/β-catenin signaling pathway, Wnt molecules
in the extracellular matrix transmit the intracellular signal
through interacting with Frizzled receptors and co-receptor
LDL receptor-related protein (Lrp) 5/6.21,22 This interaction
elicits an intracellular signaling cascade resulting in an
accumulation of non-phosphorylated β-catenin. The stabilized
non-phosphorylated β-catenin translocates into the cell
nucleus and works together with T-cell factor (TCF)/lymphoid
enhancer-binding factor (LEF) transcription factors to trigger
the transcription of Wnt target genes. Hence, the persistence
of intracellular β-catenin accumulation increases the activity of
Wnt/β-catenin signaling pathway. Recently, the Dickkopf
family has been recognized as an important regulator of this
signaling pathway, but little is known for its involvement in
proteinuric nephropathy.23
In the kidney, canonical Wnt/β-catenin signaling pathway
has been implicated in cystic kidney disease,24,25 acute kidney
injury (AKI) and diabetic nephropathy (DN).26 Recent evi-
dence have indicated that aberrant Wnt/β-catenin activities in
renal cells contributed to epithelial–mesenchymal transition
(EMT),27 fibrosis28,29 and apoptosis during nephropathy.30
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However, data on the role of Wnt/β-catenin signaling in
proteinuric nephropathy remains scarce. In this study, we
presented in vitro and in vivo evidence that protein overload
induced apoptosis in proximal tubular epithelial cells (PTECs)
via downregulation of Wnt/β-catenin signaling pathway. In
addition, the upregulation of Dickkopf-3 (Dkk-3) may act as a
novel autocrine mechanism that suppresses Wnt/β-catenin
signaling upon protein overload in PTECs.
Results
Downregulation of β-catenin expression in protein over-
loaded HK-2 cells. We first demonstrated albumin uptake in
human kidney-2 (HK-2) cells after 60-min incubation with
fluorescein (FITC)-labeled human serum albumin (HSA;
Figure 1a). In HSA-treated HK-2 cells, activation of Wnt/
β-catenin signaling was evident by the translocation of
stabilized β-catenin into cell nuclei. After 2 days of treatment,
HSA-treated cells showed significant downregulation of
active β-catenin expression in the cell nucleus. By day 4,
the reduction of both nuclear and cytosolic β-catenin
expression was further decreased to approximately 50%
compared with untreated HK-2 cells (Figure 1b). Immuno-
fluorescence staining confirmed the localization of β-catenin
at both cell membrane and nuclei of control HK-2 cells,
whereas the signal intensity abated in protein overloaded
cells (Figure 1c). Luciferase reporter assay demonstrated
downregulation of TCF/LEF promoter activities in HK-2 cells
after 2 and 4 days of HSA treatment, following a transient
upregulation of promoter activity at day 1 (Figure 1d). These
data together demonstrated the abrogation of Wnt/β-catenin
signaling pathway in HK-2 cells upon prolonged stress from
protein overload.
Upregulation of Dkk-3 expression in protein overloaded
HK-2 cells suppressed Wnt/β-catenin signaling. Dickkopf
proteins, consisting of isotypes Dkk-1 to Dkk-4, provide
feedback control of Wnt/β-catenin signaling. We postulated
that these molecules would be upregulated by protein overload
in HK-2 cells. As shown in Figures 2a and b, expression of
Dkk-3 was upregulated in at both gene and protein level in
HSA-treated HK-2 cells. Importantly, extracellular Dkk-3 has
been reported to suppress Wnt/β-catenin signaling.31 We also
showed a twofold increase in secreted Dkk-3 protein levels in
culture medium by ELISA assay (Figure 2c).
Treatment of HK-2 cells with human recombinant Dkk-3
protein reduced total β-catenin protein expression (Figures 2d
and e). Exogenous Dkk-3 also downregulated the TCF/LEF
promotor activity in HK-2 cells (Figure 2f). Notably, these
phenotypes recapitulated those of the HSA treatment,
suggesting that Dkk-3 overexpression may mediate the effect
of protein overload in HK-2 cells via an autocrine manner.
Protein overload induced apoptosis in HK-2 cells via
downregulation of Wnt/β-catenin signaling. The role of
Wnt/β-catenin signaling pathway in protein overloaded HK-2
cells was investigated using silencing RNA (siRNA)-mediated
gene silencing of β-catenin. The expression of β-catenin was
decreased gradually after 2 days in HSA-treated HK-2 cells,
whereas the suppression of β-catenin was markedly
enhanced and sustained in cells transfected with siRNA
(Figure 3a).
Protein overload induced apoptosis in HK-2 cells after HSA
treatment as indicated by an increase in gene expression ratio
of Bax/Bcl-2, and the Bax/Bcl-2 ratio was further increased
by silencing β-catenin (Figure 3b). To confirm the induction
of apoptosis, we showed that the caspase-3 activities in
these experimental groups had a similar trend to that of
terminal deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) assay (Figure 3c). In line with these observations,
the number of TUNEL-positive cells was significantly higher in
HSA-treated HK-2 cells compared with untreated cells. The
number of apoptotic cells was further increased after β-catenin
gene silencing (Figure 3d). These results indicated that
suppression of Wnt/β-catenin signaling exaggerated
apoptosis in protein overloaded HK-2 cells.
Kidney injury in the mouse model of overload protei-
nuria. Murine protein overload model was established in
6-week-old C57/BL6 mice that underwent uninephrectomy,
and followed by a high dose of bovine serum albumin (BSA;
10 mg/g body weight) or saline injection for 8 weeks
(Figure 4a). Uninephrectomized mice receiving BSA exhib-
ited significantly higher urine albumin-to-creatinine ratio
(UACR) and blood urea nitrogen (BUN) levels compared
with control mice with saline injection (Table 1). We found that
the highest UACR (15 mg/mg) was detected 1 week after
BSA injection, followed by a decline (1.6 mg/mg) at 4 weeks
and a final rebound (6.3 mg/mg) at 8 weeks. The BUN level
was also markedly increased in the BSA group and elevated
steadily during the observation period.
Renal cortical expression of AKI markers (KIM-1, NGAL
and cystatin C) were upregulated after BSA injection
for 1 week. Notably, the expression of KIM-1 and NGAL
was further upregulated after 8 weeks of BSA injection
(Figure 4b).
Dynamic Wnt/β-catenin signaling in murine protein over-
load model. The Wnt/β-catenin signaling pathway was
investigated in the kidney of mice after 4 and 8 weeks of
BSA injection. Nuclear β-catenin expression in cortical
lysates was increased significantly at 4 weeks but decreased
at 8 weeks as shown by western blot (Figure 5a). Immuno-
histochemical staining revealed that β-catenin was
primarily localized in both renal proximal and distal tubules
(Figures 5b and c). These longitudinal and dynamic changes
in Wnt/β-catenin signaling also correlated with the fluctua-
tions in UACR levels at the corresponding time points
(Table 1).
Renal expression of Dkk-3 was negatively correlated with
β-catenin expression in murine protein overload model.
Renal Dkk-3 expression was downregulated at 4 weeks but
upregulated at 8 weeks after BSA injection (Figure 6). The
expression level of Dkk-3 was negatively correlated with the
level of β-catenin at the respective time point of BSA injection.
This finding is in line with our in vitro results and suggests that
upregulation of Dkk-3 is associated with the suppression of
β-catenin.
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Abrogation of tubular Wnt/β-catenin signaling induced
tubular cell death in murine protein overload model. We
postulate that downregulated β-catenin expression in tubules
is detrimental and may exacerbate protein overload damage
on tubular injury via induction of cell death. Real-time
quantitative PCR showed that the gene expression ratio of
Bax/Bcl-2 in the kidney cortex was only upregulated after
8 weeks of BSA injection (Figure 7a). Similarly, the expres-
sion of caspase-3 and 8 was also upregulated after 8 weeks
of BSA injection (Figure 7b). Apoptosis in renal tubular cells
was confirmed by immunohistochemical staining and TUNEL
assay at 8 weeks after BSA injection (Figures 7c and d).
Collectively, these findings revealed that the increase in
tubular cell death coincided with the abrogation of intracel-
lular Wnt/β-catenin signaling.
Discussion
Progressive CKD is effected through a complex multiplicity of
tubular cell signalings,16 of which canonical Wnt/β-catenin
signaling pathway has received mounting attention recently. A
growing body of research has focused on its pivotal role in a
Figure 1 β-Catenin expression is abrogated in protein overloaded HK-2 cells. (a) Albumin uptake measurement (n= 3) in lysed HK-2 cells treated with FITC-human albumin/
non-labeled HSA. (b) HK-2 cells were treated with 5 mg/ml HSA for 2 (n= 6) and 4 (n= 6) days. Immunoblotting assays of active β-catenin expression in the nuclear fraction and
cytosolic fraction of the cell lysate. (c) Immunofluorescent staining of β-catenin in HSA-treated HK-2 cells for 4 days. Red arrows show the membrane-bound β-catenin and yellow
arrows indicate nuclear β-catenin. (d) Luciferase assay of TCF/LEF reporter activities in HSA-treated or control HK-2 cells. Bar scale= 25 μm. Graphs were expressed in
mean± S.D. *Po0.05, **Po0.001, ***Po0.0001; #Po0.01
Wnt/β-catenin in proteinuric nephropathy
DWL Wong et al
3
Cell Death and Disease
Figure 2 Dkk-3 expression is elevated in protein overloaded HK-2 cells that suppresses intracellular β-catenin expression. HK-2 cells were treated with 5 mg/ml HSA for 2
and 4 days. (a) Dkk-3 gene expression in the HSA-treated HK-2 cells for 2 days by quantitative real-time PCR (n= 8). (b) Dkk-3 levels in HSA-treated HK-2 cell lysate for 4 days
by immunoblotting (n= 8). (c) Dkk-3 protein levels in HK-2 cell culture supernatants at 4 days after HSA treatment (n= 5). (d) Change in total β-catenin levels in HK-2 cells by
immunoblotting (n= 8) after exposure to 0.1 μg/ml human recombinant Dkk-3 protein for 2 days. (e) Immunofluorescent staining of β-catenin in HK-2 cells treated with Dkk-3. Red
arrows show the membrane-bound β-catenin and yellow arrows indicate nuclear β-catenin. (f) Luciferase assay of TCF/LEF reporter activities in Dkk-3 treated or control HK-2
cells. Bar scale= 25 μm. Graphs were expressed in mean±S.D. *Po0.05, **Po0.001, ***Po0.0001, #Po0.01
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Figure 3 Loss of β-catenin/HSA stimulation promotes apoptosis in HK-2 cells. HK-2 cells were transfected with siRNA against β-catenin (si β-catenin) or mock siRNA
(40 nM) for 2 and 3 days with or without addition of HSA (5 mg/ml) for 1 and 2 days. (a) Protein levels of nuclear β-catenin in transfected HK-2 cells treated with HSA for 1 day
(n= 3) and 2 days (n= 6). (b) Bax/Bcl-2 gene expression in mock/si β-catenin transfected HK-2 cells under HSA stimulation for 2 days (n= 6). (c) Caspase-3 activity in the
corresponding groups of HK-2 cells after 2-day HSA treatment (n= 3). (d) TUNEL-positive cells after 1-day HSA stimulation in HK-2 cells with or without si β-catenin transfection
(n= 6). Red arrows indicate apoptotic nuclei. Bar scale= 25 μm. Graphs were expressed in mean± S.D. #Po0.05, ##Po0.001, ###Po0.0001
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variety of acute and chronic renal pathologies. In particular, the
dual roles of Wnt/β-catenin signaling – whether it mediates
renal injury (destructive) or repair (beneficial) – has been a
subject of intense debate.32 Here, we reported for the first time
the dynamic correlation between protein overload and Wnt/
β-catenin signaling pathway and suggested that the regulatory
protein Dkk-3 may mediate renal tubular apoptosis and the
ensuing renal injury.
Besides acting as a transcription factor, β-catenin is one of
the crucial scaffold proteins that forms a complex with
E-cadherin to support the tubular epithelial architecture. It is
postulated that β-catenin could dissociate from the cell
membrane and contribute to the cytosolic-free β-catenin
equilibrium pool.33 Once the cytosolic β-catenin is stabilized,
it translocates to the cell nucleus and triggers target gene
transcription. To mimic the persistent proteinuric state in renal
tubules of CKD patients, we used an in vitro HK-2 cell culture
system with prolonged exposure to HSA treatment (4 days).
We first demonstrated that the membrane-bound β-catenin
expression was reduced in protein overloaded HK-2 cells. The
expression of active nuclear β-catenin, which drives TCF/LEF
promoter activity, was also diminished in PTECs upon the
protein stress. These data confirmed that stress from protein
overload downregulated Wnt/β-catenin signaling pathway
in renal tubular cells. In agreement with this, stress from
exposure to cyclosporine A or high glucose has also been
associated with the suppression of Wnt/β-catenin signaling
pathway.34,35
Dkk-1 is the most well-known endogenous inhibitor of Wnt/
β-catenin signaling pathway in different disease models,36,37
however, the role of Dkk-3 is largely unknown. Here, we
found that protein overload upregulated Dkk-3 synthesis and
secretion in HK-2 cells. Exogenous Dkk-3 protein also
inhibited intracellular β-catenin expression in an autocrine
manner. Our finding that Dkk-3 suppressed tubular Wnt/
β-catenin signaling in proteinuric nephropathy was in line
with other experiment, which showed that Dkk-3 is an inducer
of apoptosis31,38 and inhibition of this protein leads to
the activation of Wnt/β-catenin signaling in lung cancer.39
Our findings should ideally be confirmed using cell-specific
Dkk-3 knockout animal models, or using a Dkk-3 neutralizing
antibody. However, both are currently not readily available.
Wnt/β-catenin signaling pathway is known to regulate cell
fate, and it is not surprising that its activation allows continuous
cell growth as observed in carcinogenesis.40 In chronic kidney
injury, protein overload causes tubular injury via induction of
cell death. Hence, we postulated that downregulation of
tubular Wnt/β-catenin expression by protein overload pro-
moted tubular apoptosis. Indeed, we found that gene silencing
of β-catenin in HK-2 cells enhanced HSA-induced apoptosis
Figure 4 Induction of protein overload in C57/BL6 mice and longitudinal changes in AKI markers. (a) Schema of protein overload model. (b) Renal cortical expression of AKI
markers (n= 6) at the respective time points. Graphs were expressed in mean± S.D. *Po0.05, **Po0.001; #Po0.05, ##Po0.001
Table 1 Urine and serum biochemistry data of UNX C57/BL6 murine receiving 10 mg/g BSA for 4 or 8 weeks
BSA injection
period
1 Week 4 Weeks 8 Weeks
UNX UNX+ BSA (10 mg/g) UNX UNX+ BSA (10 mg/g) UNX UNX+ BSA (10 mg/g)
UACR (μg/mg) 270.8± 88.8a 15 677.3±5009.6a 102.7±16.2 1621.8± 768.4a,b 112.9± 8.7c 6341.2±1486.6b,c
BUN (mg/dl) 29.8± 2.7 35.0±7.3c 29.3±1.6a 46.0± 7.2a,c 29.3± 1.9a 49.1±1.9a,c
Abbreviations: BSA, bovine serum albumin; BUN, blood urea nitrogen; UACR, urine albumin-to-creatinine ratio; UNX, uninephrectomized
UACR and BUN were measured for the experimental animals (n= 6) and expressed in mean±S.D. a=Po0.0001; b=Po0.05; c=Po0.001
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Figure 5 Expression and localization of β-catenin in kidney cortex of murine protein overloaded model at different end points. (a) Expression of β-catenin (n= 6) in kidney
cortical lysates of protein overloaded mice at 4 weeks and 8 weeks. Representative immunoblots are shown. (b) Immunohistochemical staining of tubular β-catenin (red-arrows)
on the respective kidney tissues. Bar scale= 200 μm. (c) Immunohistochemical stainings of aquaporin-1 (proximal tubule marker) and β-catenin on contiguous kidney sections.
Bar scale= 100 μm. Graphs were expressed in mean± S.D. *Po0.05; #Po0.05, ##Po0.01
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as demonstrated by the upregulation of apoptotic markers,
including the Bax/Bcl-2 gene expression ratio, caspase-3
activity and TUNEL-positive cells.
Wnt/β-catenin signaling has been implicated in other
disease models that are associated with interstitial inflamma-
tion such as diabetes35 and the murine model of unilateral
ureter obstruction.37 In AKI, ablation of β-catenin in tubular
cells aggravated kidney damage with increasing cell death.
Conversely, tubular cells were protected from apoptosis by
Wnt1 or stabilization of β-catenin30 demonstrating the
differential roles of β-catenin in kidney injury and repair. Here,
we showed evidence for the first time that β-catenin may have
dual roles during longitudinal disease progression in the
protein overload model.
In addition to apoptosis, expression levels of AKI markers
(KIM-1, NGAL and cystatin C) were also upregulated in the
renal cortex of mice with the highest proteinuria at 1 week after
protein overload. Interestingly, intrarenal KIM-1 and NGAL
expression levels were sustained up to 8 weeks after BSA
injection, indicating that the persistent acute injury response
was extended to the chronic phase.
Fluctuations in UACR appeared to be associated with the
level of β-catenin expression. Notably, amelioration of UACR
level coincided with the overexpression of tubular β-catenin at
the early phase (4 weeks). Conversely, elevation of UACR
level correlated with the decline in tubular β-catenin expres-
sion at the late phase (8 weeks). It is noteworthy that the trend
of tubular β-catenin expression under protein overload was
also in line with our in vitro results. Together with the
observation of increased tubular apoptosis toward the late
phase of murine protein overload model, we speculate that
downregulation of Wnt/β-catenin signaling is a driving force for
both proteinuria and tubular cell death. This phenomenon
suggests that heightened tubular cell death casts a negative
impact on the degree of proteinuria. One possible underlying
mechanism of suppressed Wnt/β-catenin signaling is the
induction of Dkk-3. The expression of Dkk-3 was down-
regulated at the early stage of the protein overload and
upregulated thereafter. In agreement with our in vitro data,
renal Dkk-3 expression was negatively correlated with tubular
β-catenin expression at the respective time point, suggesting
that prolonged protein overload induced tubular Dkk-3
expression and suppressed tubular β-catenin expression.
Taken together, our data support the notion that upregula-
tion of renal Dkk-3 expression in chronic proteinuric
nephropathy inhibits tubular Wnt/β-catenin signaling pathway
that unleashes the downstream detrimental events. Main-
tenance of tubular β-catenin signaling could be renoprotective
as it has anti-apoptotic property and partially ameliorates
proteinuria. Further investigation is warranted to exploit this
pathway in order to unveil new therapeutic targets for
proteinuric CKD.
Materials and Methods
Cell culture. An immortalized human PTEC cell line derived from normal kidney
named HK-2 cells was purchased (ATCC, Manassas, VA, USA). HK-2 cells were
grown in Dulbecco’s modified Eagle's medium (DMEM/F-12, GlutaMAX; Invitrogen,
Carlsbad, CA, USA), supplemented with penicillin (100 IU/ml) and streptomycin
(100 μg/ml) and 10% fetal bovine serum (FBS; Invitrogen), at 37 °C and 5% CO2.
HK-2 cells were grown to subconfluence and rendered in medium without FBS for
24 h prior further treatments. HSA (5 mg/ml) was obtained from CSL laboratory
(Parkville, Victoria, Australia) and applied to HK-2 cells for up to 4 days, with culture
media changed every 2 days. HK-2 cells were also treated with 0.1 μg/ml human
recombinant Dkk-3 (R&D Systems, Minneapolis, MN, USA).
Mouse model of protein overload nephropathy. This study was
approved by the Committee on the Use of Live Animals in Teaching and Research
(Laboratory Animal Unit, The University of Hong Kong) and was performed in
accordance with the National Institute of Health Guide for the Care and Use of
Laboratory Animals. The protocol of protein overload model was carried out
according to previous study.41 Briefly, 6-week-old C57/BL6 mice weight
approximately 20 g were divided into different groups randomly, ad libitum to food
and water. All mice were uninephrectomized under anesthesia at the age of
6 weeks before intraperitoneal injection of low endotoxin BSA (A-9430, Sigma-
Aldrich, St. Louis, MO, USA) at the dose of 10 mg/g body weight for 5 consecutive
days weekly, up to 4 and 8 weeks. Control mice were injected with equal volume of
saline. Twenty-four-hour urine and blood serum were collected at 1, 4 and 8 weeks
after BSA injection. Mice were killed at 4 and 8 weeks after BSA injection and
kidney tissues were collected. Each of the kidney tissue was dissected into half; one
half was snap-frozen in liquid nitrogen and stored at − 70 °C, the other half was
fixed with 10% formalin and embedded in paraffin for immunohistochemistry
examinations. RNA and protein were extracted from frozen kidney cortices.
siRNA transfection in HK-2 cells. HK-2 cells were transfected with siRNA
targeting CTNNB1 (ID: S438; Applied Biosystems, Carlsbad, CA, USA) by
Lipofectamine 2000 (Invitrogen) in Opti-MEM I Reduced Serum medium (Applied
Biosystems) for 6 h, followed by incubation with fresh DMEM/F-12, GlutaMAX
medium for another 18 h before they were subjected to HSA treatment. The
knockdown efficiency was verified by immunoblotting assay.
RNA isolation and quantitative real-time PCR. Total RNA was isolated
from HK-2 cells and mouse kidney cortical tissues using Trizol (Invitrogen) and
NucleoSpin Triprep (Macherey-Nagel, Duren, Germany), respectively. RNAs was
reversely transcribed according to the manufacturer’s instructions (Applied
Biosystems). Quantitative real-time PCR was performed using ABI 7500 Real-
Figure 6 Expression of Dkk-3 in kidney cortical lysate of murine protein overloaded model at different end points. Expression of Dkk-3 (n= 6) in kidney cortical lysates of
protein overloaded mice at 4 weeks and 8 weeks. Graphs were expressed in mean±S.D. *Po0.05; ####Po0.0001
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Figure 7 Expression of apoptotic markers in kidney cortex of murine protein overloaded model at different end points. (a) Renal cortical Bax/Bcl-2 gene expression ratio
measured by quantitative real-time qPCR. (b) Expression of total caspase-3 (n= 6) and 8 (n= 6) in kidney cortical lysates of protein overloaded mice at 4 weeks and 8 weeks.
(c) Immunohistochemical staining of active caspase-3 (red arrows) on the respective kidney tissues. Bar scale= 200 μm. (d) TUNEL-positive cell nuclei (blue arrows) on paraffin
kidney sections and fold change of labeled cell counts. Bar scale= 100 μm. Graphs were expressed in mean± S.D. #Po0.05, ##Po0.01, ###Po0.0001
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Time PCR System (Applied Biosystems) with SYBR Green reagent (Applied
Biosystems) and specific primers (Table 2). Relative gene expression of individual
sample was calculated after normalization with β-actin expression. All experimental
groups were compared with their respective control group using SDS software
(Applied Biosystems).
Immunoblotting assay. Total protein, cytosolic and nuclear protein were
extracted from HK-2 cells using lysis buffer and NE-PER extraction kit (Thermo
Scientific, Rockford, IL, USA) respectively, containing protease inhibitor cocktail
(Sigma-Aldrich). For mouse kidney tissue, total protein were extracted by
NucleoSpin Triprep or fractionized by the NE-PER extraction kit. Protein
Figure 7 Continued
Table 2 Primers designed for quantitative real-time PCR
Genes Primers
Forward Reverse
Human DKK-3 5′-GTAAGTTTCCCCTCTGGCTTG-3′ 5′-AAGCACCAGACTGTGAAGCCT-3′
Human BAX 5′-TTCTGACGGCAACTTCAACTGG-3′ 5′-AGGAAGTCCAATGTCCAGCC-3′
Human BCL-2 5′-GATGGGAACACTGGTGGAGGATGG-3′ 5′-TCTGGAGGGCCCACGGCAG-3′
Human β-actin 5′-TGACGTGGACATCCGCAAAG-3′ 5′-CTGGAAGGTGGACAGCGAGG-3′
Mouse NGAL 5′-ACAACCAGTTCGCCATGGTA-3′ 5′-AAGCGGGTGAAACGTTCCTT-3′
Mouse KIM-1 5′-GTCGTGGGTCTTCCTGTACTC-3′ 5′-AAACCAGAGATTCCCACACG-3′
Mouse cystatin C 5′-TGTTTGCACCAGGAGACAGT-3′ 5′-AATTGAGCAAGGCATGGCAG-3′
Mouse Bax 5′-CCCGAGCTGATCAGAACCAT-3′ 5′-GGGGTCCCGAAGTAGGAGAG-3′
Mouse Bcl-2 5′-CTTTGAGTTCGGTGGGGTCA-3′ 5′-AGTTCCACAAAGGCATCCCA-3′
Mouse β-actin 5′-TCCATCATGAAGTGTGACGT-3′ 5′-GAGCAATGATCTTGATCTTCAT-3′
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concentration was quantified by BCA Protein Assay Kit (Thermo Scientific). Equal
amount of protein was resolved by 12% SDS-PAGE and then transferred to PVDF
membranes. After blocking with 5% non-fat milk, the membranes were subjected to
overnight primary antibody incubation using antibody against active β-catenin, total
caspase-3, total caspase-8 (Cell Signalling Technology, Beverly, CA, USA),
Dicckopf-3, TATA-binding protein (TBP; Abcam, Cambridge, UK) and β-actin (Thermo
Scientific). The membranes were then incubated with peroxidase conjugated
secondary antibodies (Dako, Carpinteria, CA, USA) accordingly and visualized with
ECL prime chemiluminescnece (GE Healthcare, Buckinghamshire, UK) by using
ChemiDoc XRS+ system (Bio-Rad, Hercules, CA, USA). Protein expression levels
were quantified and normalized to β-actin/TBP by Image Lab software (Bio-Rad).
ELISA. The level of Dkk-3 from HK-2 culture medium was measured by a
commercial ELISA kit (Abcam). Mouse urinary albumin was measured by mouse
albumin ELISA quantitation kit (Bethyl Laboratories, Montgomery, TX, USA). Urine
creatinine and serum BUN were quantified by enzymatic assays (Stanbio
Laboratory, Boerne, TX, USA).
Caspase-3 activity assay. HK-2 cells were subjected to the albumin or
siRNA treatment as described and lysed for caspase-3 activity assay, according to
the manufacturer’s protocol of ApoAlert Caspase Colorimetric Assay Kit (Clontech
Laboratories, Mountain View, CA, USA). Briefly, the cell lysates were incubated with
the chromophore p-nitroaniline (pNA) linked with the specific caspase-3 substrate.
Caspase-3 activity was measured by spectrophotometric detection of released pNA
after the cleavage by active caspase-3.
Immunohistochemical staining. Paraffin-embedded kidney tissue sec-
tions (4 μm) were de-paraffinized, rehydrated with concentration gradient of ethanol.
The sections were subjected to antigen retrieval step, by microwave-based method
in 10 mM citrate buffer, or incubation with 20 ug/ml proteinase k (Qiagen, Valencia,
CA, USA) for 10 min Then, the sections were quenched in 3% hydrogen peroxide
for 10 min and incubated with 2% BSA to block nonspecific binding. Primary
antibodies against β-catenin (BD Bioscience, San Jose, CA, USA), aquaporin-1 and
active caspase-3 (Abcam) were added to the sections overnight and subsequently
with secondary peroxidase conjugated antibodies (Dako) or alkaline phosphatase
conjugated antibodies (Enzo Life Sciences, Farmingdale, NY, USA) for 1 h. The
sections were developed by using DAB substrate from the Envision Plus system
(Dako) or HIGHDEF red chromogen (Enzo Life Sciences), followed by counterstain
with CAT hematoxylin (Biocare Medical, Walnut Creek, CA, USA). The slides were
then dehydrated with ethanol and xylene before mounting.
Immunofluorescence staining. HK-2 cells were seeded on chamber slides
(Thermo Scientific) and incubated with HSA or Dkk-3 treatments. Cells were fixed
with 4% paraformaldehyde (Sigma-Aldrich), followed by permeabilization in 0.25%
Triton X 100 and 2% BSA (Sigma-Aldrich) incubation. The slides were then
incubated in primary antibody against β-catenin (BD Bioscience) overnight
thereafter incubated with the corresponding FITC-conjugated secondary antibody
(Dako). The chamber slides were mounted with ProLong antifade mounting medium
(Invitrogen) and examined under fluorescence microscope (400X; Leica, Bensheim,
Germany).
Luciferase reporter assay. Nano-Glo Dual-Luciferase Reporter Assay
System (Promega, Madison, WI, USA) was used to measure the TCF/LEF
promoter activities. HK-2 cells were seeded in 96-well plate and co-transfected with
pGL4.53 firefly luciferase (Fluc) and pGL4 (luc2CP/TCF-LEF RE/Hygro) NanoLuc
luciferase (Nluc) plasmid using Lipofectamine 2000 (Invitrogen). Transfected cells
were treated HSA and Dkk-3 for the respective duration lengths, then lysed with
lysis buffer with Fluc substrate and incubated on an orbital shaker for 10 min. Fluc
signals were then quenched and following by reaction with Nluc substrate. The
signals in arbitrary unit (AU) from both Nluc and Fluc were measured by a
luminometer (BMG Labtech GmbH, Ortenberg, Germany). The promoter activities
were calculated by the ratio of respective AU values of Nluc/Fluc.
Albumin uptake. FITC-conjugated HSA, 1 mg/ml (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA, USA) was treated to HK-2 cells for albumin
uptake measurement. HK-2 cells were seeded in 96-well black plate with clear
bottom and treated with the labeled albumin for the respective time points. Cells
were lysed with 0.1% SDS and the fluorescence intensities were measured by a
FLUOstar Omega Microplate Reader (BMG Labtech).
TUNEL assay
In vitro assay: HK-2 cells were seeded in chamber slides and treated with HSA
or siRNA transfection. Apoptotic cells were detected by ApopTag Peroxidase In Situ
Apoptosis Detection Kit (Millipore, Bedford, MA, USA). The cells were fixed with 4%
paraformaldehyde (Sigma-Aldrich), permeabilized with ethanol:acetic acid, 2 : 1
(v : v) and followed by protocol according to the manufacturer’s instructions. Cells
were counterstained with Methyl Green (Dako) and were examined under light
microscopy (200X). Images were taken on non-overlap areas, TUNEL-labeled cells/
total cell number ratios were counted for individual image and averaged for each
experimental sample.
In vivo assay: Deparaffinized, rehydrated and antigen retrieved sections of
mouse tissue were subjected to apoptotic analysis by In Situ Cell Death Detection
kit, POD (Roche Applied Sciences, Indianapolis, IN, USA). For mouse tissue
sections, approximately 10 images of cortical area with at least one glomerulus
(400X) were taken. TUNEL-labeled cells/total cell number ratios were counted for
individual image and averaged for each experimental sample.
Statistical analysis. All data were expressed as mean± S.D. from three
independent experiments. Two/one-way ANOVA with Tukey's multiple comparison
test or t-test were used to calculate the difference between experimental groups.
GraphPad Prism v.4 (GraphPad Software, San Diego, CA, USA) was used to
evaluate the data. Po0.05 was considered statistically significant.
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